Literature DB >> 27220866

Spinocerebellar ataxia: relationship between phenotype and genotype - a review.

Y-M Sun1, C Lu2,3, Z-Y Wu4,5.   

Abstract

Spinocerebellar ataxia (SCA) comprises a large group of heterogeneous neurodegenerative disorders inherited in an autosomal dominant fashion. It is characterized by progressive cerebellar ataxia with oculomotor dysfunction, dysarthria, pyramidal signs, extrapyramidal signs, pigmentary retinopathy, peripheral neuropathy, cognitive impairment and other symptoms. It is classified according to the clinical manifestations or genetic nosology. To date, 40 SCAs have been characterized, and include SCA1-40. The pathogenic genes of 28 SCAs were identified. In recent years, with the widespread clinical use of next-generation sequencing, the genes underlying SCAs, and the mutants as well as the affected phenotypes were identified. These advances elucidated the phenotype-genotype relationship in SCAs. We reviewed the recent clinical advances, genetic features and phenotype-genotype correlations involving each SCA and its differentiation. The heterogeneity of the disease and the genetic diagnosis might be attributed to the regional distribution and clinical characteristics. Therefore, recognition of the phenotype-genotype relationship facilitates genetic testing, prognosis and monitoring of symptoms.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  autosomal dominant cerebellar ataxias; genotype; phenotype; spinocerebellar ataxia

Mesh:

Substances:

Year:  2016        PMID: 27220866     DOI: 10.1111/cge.12808

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  42 in total

1.  Neurocognitive Characterization of an SCA28 Family Caused by a Novel AFG3L2 Gene Mutation.

Authors:  Laszlo Szpisjak; Viola L Nemeth; Noemi Szepfalusi; Denes Zadori; Zoltan Maroti; Tibor Kalmar; Laszlo Vecsei; Peter Klivenyi
Journal:  Cerebellum       Date:  2017-12       Impact factor: 3.847

2.  COQ4 Mutation Leads to Childhood-Onset Ataxia Improved by CoQ10 Administration.

Authors:  Ahmet Okay Caglayan; Hakan Gumus; Erin Sandford; Thomas L Kubisiak; Qianyi Ma; A Bilge Ozel; Huseyin Per; Jun Z Li; Vikram G Shakkottai; Margit Burmeister
Journal:  Cerebellum       Date:  2019-06       Impact factor: 3.847

3.  MTCL1 plays an essential role in maintaining Purkinje neuron axon initial segment.

Authors:  Tomoko Satake; Kazunari Yamashita; Kenji Hayashi; Satoko Miyatake; Miwa Tamura-Nakano; Hiroshi Doi; Yasuhide Furuta; Go Shioi; Eriko Miura; Yukari H Takeo; Kunihiro Yoshida; Hiroyuki Yahikozawa; Naomichi Matsumoto; Michisuke Yuzaki; Atsushi Suzuki
Journal:  EMBO J       Date:  2017-03-10       Impact factor: 11.598

4.  Genetic and clinical features of Chinese patients with mitochondrial ataxia identified by targeted next-generation sequencing.

Authors:  Hai-Lin Dong; Yin Ma; Quan-Fu Li; Yi-Chu Du; Lu Yang; Sheng Chen; Zhi-Ying Wu
Journal:  CNS Neurosci Ther       Date:  2018-05-13       Impact factor: 5.243

Review 5.  Role of Microglia in Ataxias.

Authors:  Austin Ferro; Carrie Sheeler; Juao-Guilherme Rosa; Marija Cvetanovic
Journal:  J Mol Biol       Date:  2019-01-18       Impact factor: 5.469

6.  An Improved Method for Differentiating Mouse Embryonic Stem Cells into Cerebellar Purkinje Neurons.

Authors:  Christopher J Alexander; John A Hammer
Journal:  Cerebellum       Date:  2019-06       Impact factor: 3.847

Review 7.  Autism genetics: opportunities and challenges for clinical translation.

Authors:  Jacob A S Vorstman; Jeremy R Parr; Daniel Moreno-De-Luca; Richard J L Anney; John I Nurnberger; Joachim F Hallmayer
Journal:  Nat Rev Genet       Date:  2017-03-06       Impact factor: 53.242

Review 8.  Antisense Drugs Make Sense for Neurological Diseases.

Authors:  C Frank Bennett; Holly B Kordasiewicz; Don W Cleveland
Journal:  Annu Rev Pharmacol Toxicol       Date:  2020-10-09       Impact factor: 13.820

9.  Ddhd1 knockout mouse as a model of locomotive and physiological abnormality in familial spastic paraplegia.

Authors:  Takuya Morikawa; Hiroaki Ohishi; Kengo Kosaka; Tomofumi Shimojo; Akihiro Nagano; Itsuki Taniguchi; Ryuta Fujioka; Kosei Moriyama; Motoko Unoki; Masatomo Takahashi; Motonao Nakao; Yoshihiro Izumi; Takeshi Bamba; Hiroyuki Sasaki; Shiroh Miura; Hiroki Shibata
Journal:  Biosci Rep       Date:  2021-02-26       Impact factor: 3.840

10.  Redox Imbalance Associates with Clinical Worsening in Spinocerebellar Ataxia Type 2.

Authors:  Almaguer-Gotay Dennis; Luis E Almaguer-Mederos; Rodríguez-Aguilera Raúl; Rodríguez-Labrada Roberto; Velázquez-Pérez Luis; Cuello-Almarales Dany; González-Zaldívar Yanetza; Vázquez-Mojena Yaimeé; Estupiñán-Domínguez Annelié; Peña-Acosta Arnoy; Torres-Vega Reydenis
Journal:  Oxid Med Cell Longev       Date:  2021-02-19       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.